![Chemical structure of 4H-FURO[3,2-C]PYRAN-2(6H)-ONE, 4-HYDROXY-, CAS 149-29-1](https://api.angenesci.com/structure/1835/149-29-1.png)
No data
No data
No data
| CAS Number | 149-29-1 |
| Catalog Number | AG001LCB(AGN-PC-0JK6Z5) |
| Chemical Name | 4H-FURO[3,2-C]PYRAN-2(6H)-ONE, 4-HYDROXY- |
| EC Number | 205-735-2 |
| IUPAC Name | 4-hydroxy-4,6-dihydrofuro[3,2-c]pyran-2-one |
| InChI | InChI=1S/C7H6O4/c8-6-3-4-5(11-6)1-2-10-7(4)9/h1,3,7,9H,2H2 |
| InChI Key | ZRWPUFFVAOMMNM-UHFFFAOYSA-N |
| MDL Number | MFCD00005858 |
| Molecular Formula | C7H6O4 |
| Molecular Weight | 154.1201 |
| SMILES | C1C=C2C(=CC(=O)O2)C(O1)O |
| Synonyms | Patulin,
patulin,
Clavacin,
Expansin,
Clavatin,
Claviform,
Expansine,
Patuline,
149-29-1,
Clairformin,
Claviformin,
Gigantin,
Leucopin,
Tercinin,
Mycoin,
Mycoine C3,
Mycoin C3,
Penicidin,
Mycosin,
Penatin,
Terinin,
Mycoin C,
4-Hydroxy-4H-furo[3,2-c]pyran-2(6H)-one,
Sch-351633,
NSC 8120,
NSC 32951,
4-Hydroxy-4H-furo(3,2-C)pyran-2(6H)-one,
4H-Furo[3,2-c]pyran-2(6H)-one, 4-hydroxy-,
CCRIS 4940,
(2,4-Dihydroxy-2H-pyran-3(6H)-ylidene)acetic acid, 3,4-lactone,
4,6-Dihydro-4-hydroxy-2H-furo(3,2-c)pyran-2-one,
HSDB 3522,
NSC8120,
NSC32951,
EINECS 205-735-2,
MFCD00005858,
4H-Furo(3,2-c)pyran-2(6H)-one, 4-hydroxy-,
SCH 351633,
(2,4-Dihydroxy-2H-pyran-3(6H)-ylidene)acetic acid-3,4-lactone,
BRN 0149675,
CHEMBL294018,
CHEBI:74926,
4-hydroxy-4,6-dihydrofuro[3,2-c]pyran-2-one,
ZRWPUFFVAOMMNM-UHFFFAOYSA-N,
4H-Furo(3,3-c)pyran-2(6H)-one, 4-hydroxy-,
Acetic acid, (2,4-dihydroxy-2H-pyran-3(6H)-ylidene)-, 3,4-lactone,
4,6-dihydro-4-hydroxy-2H-furo[3,2-c]pyran-2-one,
Patulin, 99%,
(2, 3,4-lactone,
2,4-Dihydroxy-2H-pyran-delta-3(6H),alpha-acetic acid-3,4-lactone,
2H-Pyran-delta(sup 3(6H),alpha)-acetic acid, 2,4-dihydroxy-, 3,4-lactone,
4-Hydroxy-4,6-dihydrofuro[4,5-c]pyran-2-one,
4H-Furo[3, 4-hydroxy-,
4-hydroxy-4,6-dihydro-2H-furo[3,2-c]pyran-2-one,
2,.alpha.-acetic acid, 3,4-lactone,
WLN: T56 BOV GO IU & TJ FQ,
748133-69-9,
SR-05000002238,
Clavicin,
Clavitin,
Expansion,
2H-Pyran-.delta.(sup 3(6H), 2,4-dihydroxy-, 3,4-lactone,
Acetic acid,4-dihydroxy-2H-pyran-3(6H)-ylidene)-, 3,4-lactone,
Gigantic acid?,
Spectrum_000015,
Antibiotic YS 1649,
AC1L1IQY,
Spectrum3_000796,
Spectrum4_000753,
Spectrum5_001659,
Standard Solution Patulin,
PATULIN 13C3,
Antibiotic Sch 351633,
Patulin, reference material,
Neuro_000008,
SCHEMBL29056,
BSPBio_002532,
KBioGR_001106,
KBioSS_000355,
5-18-03-00005 (Beilstein Handbook Reference),
DivK1c_000438,
SPECTRUM1503904,
MEGxm0_000442,
DTXSID2021101,
ACon1_002106,
HMS501F20,
KBio1_000438,
KBio2_000355,
KBio2_002923,
KBio2_005491,
KBio3_001752,
NINDS_000438,
ZX-AFC003098,
HMS1923M19,
Patulin, >=98.0% (HPLC),
BCP29227,
NSC-8120,
BDBM50158841,
CP0142,
LS-868,
NSC-32951,
AKOS015904103,
CCG-208451,
FCH1114665,
YS 1649,
IDI1_000438,
SMP1_000230,
NCGC00095272-01,
NCGC00095272-02,
NCGC00095272-03,
NCGC00095272-04,
NCGC00095272-05,
CC-33482,
NCI60_041782,
TR-006033,
4-Hydroxy-4H,6H-furo[3,2-c]pyran-2-one,
FT-0631849,
ST50824441,
4-Hydroxy-4H-Furo(3,3-c)pyran-2(6H)-one,
C16748,
4-hydroxy-2H,4H,6H-furo[3,2-c]pyran-2-one,
4-hydroxy-6-hydro-4H-furano[3,2-c]pyran-2-one,
C-30428,
J-008576,
SR-05000002238-2,
SR-05000002238-3,
I14-18325,
4-oC>>u-4H-ss>>[3,2-c]ssAa<<-2(6H)-I feminine,
2,4-Dihydroxy-2H-pyran-alpha -acetic acid, 3, 4-lactone,
2-Hydroxy-3,7-dioxabicyclo[4.3.0]nona-5,9-dien-8-one,
4-Hydroxy-4H-furo[3,2-c]pyran-2(6H)-one, 9CI, 8CI,
2H-Pyran-.delta.(sup 3(6H), 2,4-dihydroxy-,3,4-lactone,
2H-Pyran-alpha )-acetic acid, 2, 4-dihydroxy-,3,4-lactone,
2H-Pyran-alpha )-acetic acid, 2,4-dihydroxy-, 3,4-lactone,
Patulin solution, 100 mug/mL in acetonitrile, analytical standard,
Patulin solution, 100 mug/mL in chloroform, analytical standard,
2,4-Dihydroxy-2H-pyran-.delta.-3(6H),.alpha.-acetic acid, 3,4-lactone,
2H-Pyran-.delta.(3(6H),.alpha.)-acetic acid, 2,4-dihydroxy-,3,4-lactone,
Patulin solution, certified reference material, 100 mug/mL in chloroform, ampule of 1 mL,
247172-18-5,
flavicin,
UNII-95X2BV4W8R,
D0LB4A,
C7H6O4,
95X2BV4W8R,
CID4696,
C7-H6-O4,
Patulin, 98% - 10MG 10mg,
ZINC03874615,
D010365,
PAT,
|
| Complexity | 264 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 154.027g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 11 |
| Hydrogen Bond Acceptor Count | 4 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 154.121g/mol |
| Monoisotopic Mass | 154.027g/mol |
| Rotatable Bond Count | 0 |
| Topological Polar Surface Area | 55.8A^2 |
| Undefined Atom Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | -1 |
| Symbol: | |
| Hazard statements | |
| Precautionary statements | |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

